会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明公开
    • 4-AMINO-6-PHENYL-5,6-DIHYDROIMIDAZO[1,5-A]PYRAZIN-3(2H)-ONE DERIVATIVES AS INHIBITORS OF BETA-SECRETASE (BACE)
    • 4-氨基-6-苯基-5,6-二氢吲哚并[1,5-a]吡嗪-3(2H) - 衍生物ALS抑制剂β-谷维素(BACE)
    • EP3008067A1
    • 2016-04-20
    • EP14732131.9
    • 2014-06-12
    • Janssen Pharmaceutica N.V.
    • OEHLRICH, DanielGIJSEN, Henricus, Jacobus, Maria
    • C07D487/04A61K31/4985A61P25/28
    • C07D487/04
    • The present invention relates to novel 5,6-dihydroimidazo[1,5-a]pyrazin-3(2
      H )-one derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, in particular BACE1 and/or BACE2 (wherein BACE1, is also known as Asp2, or memapsin2 and BACE2 is also known as Asp1, Memapsin 1 or DRAP). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which beta-secretase is involved, such as Alzheimer's disease (AD), mild cognitive impairment, senility, dementia, dementia with Lewy bodies, Down's syndrome, dementia associated with stroke, dementia associated with Parkinson's disease, dementia of the Alzheimer's type, dementia associated with beta-amyloid, age-related macular degeneration, type 2 diabetes and other metabolic disorders.
    • 本发明涉及作为β-分泌酶抑制剂的新的5,6-二氢咪唑并[1,5-a]吡嗪-3(2H) - 酮衍生物,也称为β位点淀粉样蛋白切割酶BACE,特别是BACE1和 /或BACE2(其中BACE1,也称为Asp2或memapsin2,BACE2也称为Asp1,Memapsin 1或DRAP)。 本发明还涉及包含这种化合物的药物组合物,制备这些化合物和组合物的方法,以及这些化合物和组合物用于预防和治疗其中涉及β-分泌酶的疾病如阿尔茨海默氏病的用途( AD),轻度认知障碍,衰老,痴呆,路易体痴呆,唐氏综合征,与中风相关的痴呆,与帕金森病相关的痴呆,阿尔茨海默氏型痴呆,与β-淀粉样变性相关的痴呆,年龄相关性黄斑变性,类型 2型糖尿病等代谢紊乱。